# A Phase II, Placebo-controlled Trial Evaluating the Efficacy of Antroquinonol in Patients With Atopic Dermatitis

> **NCT04110873** · PHASE2 · TERMINATED · sponsor: **Chung Shan Medical University** · enrollment: 14 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** Antroquinonol Capsule 50mg
- **DRUG:** Antroquinonol Capsule 100mg
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT04110873
- **Lead sponsor:** Chung Shan Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-07-27
- **Primary completion:** 2019-06-25
- **Final completion:** 2019-06-25
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** It was hard to find suitable subject due to strict enrollment criteria.
- **Last updated:** 2019-10-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04110873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04110873, "A Phase II, Placebo-controlled Trial Evaluating the Efficacy of Antroquinonol in Patients With Atopic Dermatitis". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT04110873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*